[1]Takasaki,Ichiro;Ogashi,Haruna;Okada,Takuya;Shimodaira,Ayaka;Hayakawa,Daichi;Watanabe,Ai;Miyata,Atsuro;Kurihara,Takashi;Gouda,Hiroaki;Toyooka,Naoki[EuropeanJournalofMedicinalChemistry,2020,vol.186]
10006-67-4
1998-86-3
92847-41-1
91349-19-8
91348-51-5
91064-26-5
338417-50-8 | Methyl 3-(2-chloro-6-fluorophenyl)-5-[2-(dimethylamino)vinyl]-4-isoxazolecarboxylate | AA00BYOX | MFCD00127467
370864-72-5 | 3-(Piperidin-4-yl)benzonitrile | AA00BYUX | MFCD03839908
33107-73-2 | 1-(6-Chloro-9-methyl-9H-carbazol-3-yl)ethanone | AA00BYYT | MFCD00814137
428847-37-4 | 3-ETHOXY-4-PROP-2-YNYLOXY-BENZALDEHYDE | AA00BZ3Z | MFCD02380174
3606-45-9 | Dihydrosanguinarine | AA00BZ9L | MFCD00872066
33696-00-3 | 4-Bromo-2-nitroanisole | AA00BZEX | MFCD00055529
344298-96-0 | 4-AMINODIPHENYL-D9 | AA00BZL8 | MFCD01074066
3460-04-6 | 3-Chloro-n-phenylpropanamide | AA00BZPE | MFCD00018971
356086-86-7 | 4-(p-Tolylamino)butan-1-ol | AA00BZX4 | MFCD02603506
3302-06-5 | 3,4-Dimethylpentanoic acid | AA00C030 | MFCD02258589